Skip to main content

Biosleep uses a proprietary algorithm and cloud-based analytics to conveniently and accurately diagnose sleep apnea.  The economic impact of undiagnosed sleep apnea is roughly $150B per annum. Less than 20% of patients suffering with obstructive sleep apnea have been currently diagnosed.